24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
29.89% |
|
ANTIBODY DYNAMICS SIMULATION |
24.14% |
|
IL 2 DYNAMICS SIMULATIONS |
20.69% |
|
IL 2 FORCE FIELD BENCHMARKING |
13.79% |
|
MEMBRANE TRANSPORT |
11.49% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
34.06% |
|
ANTIBODY DYNAMICS SIMULATION |
22.71% |
|
IL 2 FORCE FIELD BENCHMARKING |
17.73% |
|
IL 2 DYNAMICS SIMULATIONS |
12.75% |
|
PARKINSONS |
10.89% |
|
MEMBRANE TRANSPORT |
1.56% |
|
CANCER |
.31% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS SIMULATION |
20.68% |
|
ENZYME DYNAMICS |
17.23% |
|
IL 2 FORCE FIELD BENCHMARKING |
12.14% |
|
ANTIBODY AFFINITY MATURATION |
12.06% |
|
ANTIBODY DYNAMICS |
11.12% |
|
IL 2 DYNAMICS SIMULATIONS |
6.48% |
|
IL 2 RECEPTOR DYNAMICS |
6.24% |
|
ALZHEIMERS |
5.7% |
|
PARKINSONS |
2.25% |
|
UNSPECIFIED |
1.36% |
|
STP6 SUGAR TRANSPORT |
1.29% |
|
SUCROSE TRANSPORT PLANTS |
.66% |
|
MEMBRANE TRANSPORT |
.66% |
|
CANCER |
.65% |
|
ATSTP10 SUCROSE TRANSPORT |
.45% |
|
ATSTP10 TRANSPORT MECHANISM |
.45% |
|
PLANT SUCROSE TRANSPORT |
.37% |
|
ANTIBODY MATURATION SIMULATION |
.23% |